Results for this period
Interim period (second quarter)1 October 2025–31 March 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The company sought to expand sales by strengthening original products under the health theme, maintaining its customer base, developing new products at affordable price points, reviewing the specifications of existing products, and selling products at morning markets and special events. The review of product specifications improved the gross profit margin.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 October 2025–31 March 2026 |
| Net Sales | ¥1,656 million (YoY +8.7%) |
| Operating profit | ¥70 million (YoY +19.4%) |
| Ordinary income | ¥73 million (YoY +18.4%) |
| Profit attributable to owners of the parent | ¥66 million (YoY +67.8%) |
| Net income per share | ¥4.70 |
| Equity ratio | End of the current fiscal period 74.7 / End of previous period 76.8 |
| Total assets | ¥1,493 million |
| Net assets | ¥1,115 million |
| Cash flows from operating activities | ¥121,235 thousand |
| Cash flows from investing activities | ¥-8,769 thousand |
| Cash and cash equivalents at end of period | ¥722,122 thousand |
| Annual Dividend Forecast | ¥0.00 → To be determined |
| Segment revenue | Retail Business ¥1,498,096 thousand (YoY +10.1%), Other Businesses ¥158,556 thousand (YoY -2.8%) |
| Segment profit | Retail Business ¥134,838 thousand (YoY +3.6%), Other Businesses ¥10,090 thousand (YoY +0.3%) |
| Depreciation and amortization | ¥7,073 thousand |
| Impairment loss | ¥611 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥1,598 thousand, Other ¥10 thousand / Extraordinary loss Impairment Losses ¥611 thousand, Loss on Disposal of Fixed Assets ¥1,079 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 14,157,780 Shares |
| Treasury Shares at Period-End | 0 shares |
| Factors Behind Changes in Business Performance | The company sought to expand sales by strengthening original products under the health theme, maintaining its customer base, developing new products at affordable price points, reviewing the specifications of existing products, and selling products at morning markets and special events. The review of product specifications improved the gross profit margin. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company strengthened its original products under the “health” theme and worked to maintain its customer base. It sought to expand sales through the development of new products at affordable price points, revisions to the specifications of existing products, and sales at morning markets and special events. It explained that the review of product specifications improved the gross profit margin.